Tirzepatide is a novel peptide designed to support weight loss and improve metabolic health by acting as a dual or multi-receptor agonist. It primarily targets receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), two key hormones involved in regulating appetite, blood sugar levels, and energy balance. By activating these pathways, Tirzepatide helps reduce hunger, slow gastric emptying, and enhance satiety, leading to decreased food intake and improved glycemic control. Its unique ability to influence multiple hormonal systems makes it a promising option for individuals managing obesity and type 2 diabetes

In the human body, Tirzepatide works by stimulating insulin secretion in response to elevated blood glucose while simultaneously suppressing glucagon release, which helps lower blood sugar levels. Activation of GIP and GLP-1 receptors also improves insulin sensitivity and promotes fat metabolism, contributing to weight reduction and better metabolic flexibility. These combined effects result in improved blood glucose regulation, reduced visceral fat, and enhanced overall energy balance. Because of its broad mechanism of action, Tirzepatide is considered a next-generation therapy for metabolic disorders, offering comprehensive benefits for weight management and long-term metabolic health.

Reconstitution Protocol

• Diluent/Amount: 1 mL Bacteriostatic Water

Dosage Instructions

• Suggested Dosage:
  • (Start) Weeks 1-4: 1mg (10units), 3x/week.
  • Weeks 5- Maintenance: Titrate as needed by 0.5mg (5units per dose.)
• Dosage Frequency: 3 times a week. Fasted PM
• Route: Subcutaneous
• Cycle Duration: maintenance as needed.

Peptides to Stack with Tirzepatide:

• Retatrutide: Advanced multi-agonist synergy for aggressive fat loss and metabolic remodeling (when cycling strategies are used).
• 5-Amino-1MQ: Improves insulin sensitivity and adipose metabolism.
• MOTS-C: Enhances mitochondrial metabolic signaling during recomposition.
• Telmisartan: Improves cardiometabolic health alongside weight reduction.
• SS-31: Supports mitochondrial resilience under increased metabolic demand.

Tirzepatide is a novel peptide designed to support weight loss and improve metabolic health by acting as a dual or multi-receptor agonist. It primarily targets receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), two key hormones involved in regulating appetite, blood sugar levels, and energy balance. By activating these pathways, Tirzepatide helps reduce hunger, slow gastric emptying, and enhance satiety, leading to decreased food intake and improved glycemic control. Its unique ability to influence multiple hormonal systems makes it a promising option for individuals managing obesity and type 2 diabetes.

In the human body, Tirzepatide works by stimulating insulin secretion in response to elevated blood glucose while simultaneously suppressing glucagon release, which helps lower blood sugar levels. Activation of GIP and GLP-1 receptors also improves insulin sensitivity and promotes fat metabolism, contributing to weight reduction and better metabolic flexibility. These combined effects result in improved blood glucose regulation, reduced visceral fat, and enhanced overall energy balance. Because of its broad mechanism of action, Tirzepatide is considered a next-generation therapy for metabolic disorders, offering comprehensive benefits for weight management and long-term metabolic health.

Reconstitution Protocol

• Diluent/Amount: 2 mL Bacteriostatic Water

Dosage Instructions

• Suggested Dosage:
  • (Start) Weeks 1-4: 1mg (10units), 3x/week.
  • Weeks 5- Maintenance: Titrate as needed by 0.5mg (5units per dose)
• Dosage Frequency: 3 times a week.
• Route: Subcutaneous
• Cycle Duration: maintenance as needed.

Notes

• Subcutaneous stomach injections
• Inject in PM, in fasted state.
• Titrate as needed
• Max dose is 15mg (150 units)/ week
• Injection site may be tender/ irritation after injection.

Tirzepatide is a groundbreaking peptide that acts as a dual GLP-1 and GIP receptor agonist, making it one of the most effective treatments for fat loss and metabolic health. By combining the effects of both glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP), Tirzepatide works to reduce appetite, improve insulin sensitivity, enhance glucose metabolism, and accelerate fat burning. Its dual mechanism of action helps to reduce hunger and food intake while boosting energy expenditure and promoting fat oxidation, making it one of the most powerful tools for weight management. In clinical studies, Tirzepatide has shown impressive results, with individuals losing up to 20-25% of body weight, while also improving cardiovascular health and metabolic markers like blood pressure and cholesterol.

Peptides to Stack with Tirzepatide:

• CJC-1295 + Ipamorelin: Enhances growth hormone release, promoting fat breakdown and muscle preservation, which works synergistically with Tirzepatide’s appetite-suppressing and fat-burning effects.
• AOD-9604: Directly targets fat metabolism and lipolysis (fat breakdown), providing a more specific fat-burning mechanism to complement Tirzepatide’s broader metabolic effects.
• 5-Amino-1MQ: Increases cellular energy expenditure and reduces fat accumulation by inhibiting NNMT, amplifying Tirzepatide’s fat-loss benefits.
• BPC-157: Supports tissue repair and recovery, especially beneficial for maintaining muscle mass and reducing inflammation while on a fat-loss regimen with Tirzepatide.

Tirzepatide is a novel peptide designed to support weight loss and improve metabolic health by acting as a dual or multi-receptor agonist. It primarily targets receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), two key hormones involved in regulating appetite, blood sugar levels, and energy balance. By activating these pathways, Tirzepatide helps reduce hunger, slow gastric emptying, and enhance satiety, leading to decreased food intake and improved glycemic control. Its unique ability to influence multiple hormonal systems makes it a promising option for individuals managing obesity and type 2 diabetes.

In the human body, Tirzepatide works by stimulating insulin secretion in response to elevated blood glucose while simultaneously suppressing glucagon release, which helps lower blood sugar levels. Activation of GIP and GLP-1 receptors also improves insulin sensitivity and promotes fat metabolism, contributing to weight reduction and better metabolic flexibility. These combined effects result in improved blood glucose regulation, reduced visceral fat, and enhanced overall energy balance. Because of its broad mechanism of action, Tirzepatide is considered a next-generation therapy for metabolic disorders, offering comprehensive benefits for weight management and long-term metabolic health.

Reconstitution Protocol

• Diluent/Amount: 3 mL Bacteriostatic Water

Dosage Instructions

• Suggested Dosage:
  • (Start) Weeks 1-4: 1mg (10units), 3x/week.
  • Weeks 5- Maintenance: Titrate as needed by 0.5mg (5units per dose)
• Dosage Frequency: 3 times a week.
• Route: Subcutaneous
• Cycle Duration: maintenance as needed.

Tirzepatide is a groundbreaking peptide that acts as a dual GLP-1 and GIP receptor agonist, making it one of the most effective treatments for fat loss and metabolic health. By combining the effects of both glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP), Tirzepatide works to reduce appetite, improve insulin sensitivity, enhance glucose metabolism, and accelerate fat burning. Its dual mechanism of action helps to reduce hunger and food intake while boosting energy expenditure and promoting fat oxidation, making it one of the most powerful tools for weight management. In clinical studies, Tirzepatide has shown impressive results, with individuals losing up to 20-25% of body weight, while also improving cardiovascular health and metabolic markers like blood pressure and cholesterol.

Peptides to stack with Tirzepatide:

• CJC-1295 + Ipamorelin: Enhances growth hormone release, promoting fat breakdown and muscle preservation, which works synergistically with Tirzepatide’s appetite-suppressing and fat-burning effects.
• AOD-9604: Directly targets fat metabolism and lipolysis (fat breakdown), providing a more specific fat-burning mechanism to complement Tirzepatide’s broader metabolic effects.
• 5-Amino-1MQ: Increases cellular energy expenditure and reduces fat accumulation by inhibiting NNMT, amplifying Tirzepatide’s fat-loss benefits.
• BPC-157: Supports tissue repair and recovery, especially beneficial for maintaining muscle mass and reducing inflammation while on a fat-loss regimen with Tirzepatide.

GLP-2, TRZ-2, Etc.

Cycle Duration:
Maintenance – As needed

Bottles Required:
Bottle lasts 5–10 weeks (dependent on individual dosing)

RECONSTITUTION

• Mix 6mL of bacteriostatic water into the vial, aiming the stream down the side of vial.

Dosage & Schedule:

• Week 1: Inject 10 units (1mg), 3x/week
• Increase dose as needed each week until desired appetite reduction. Increase in 5 unit/injection increments (or decrease dose as needed)

Example Schedule:

• Wk 1 & 2: 10 units (1mg), 3x/week (M, W, F)
• Wks 3–6: 15 units (1.5mg), 3x/week, etc.
• Everyone’s body handles this differently, you must feel yourself out until you’ve reached the dose that is right for you.

Notes:

• Inject SubQ at bedtime, in fasted state.
• Max dose 15mg (150 units)/week
• Injection site may be tender/irritated after injection.

EXPECTED BENEFITS

• Decreased appetite
• Increased food portion control
• Rapid Weight Loss
• Reduction in brown adipose tissue
• Reduced inflammation
• Increased metabolic health
• Lower blood sugar levels, increased insulin sensitivity
• Regulates glucose in brain and body